coronavirus

Protocol for patients attending in-person appointments or treatment at The London Skin and Hair Clinic during covid-19 (Updated 13th October 2020) This page contains important information relating to your in-person appointment at our Holborn clinic during covid-19. All of our services are delivered in line with the UK government’s social distancing measures and fully compliant …

Protocol for in-person appointments at The London Skin and Hair Clinic Read More »

The London Skin and Hair Clinic is open for face to face medical dermatology appointments and treatment where medically necessary, Monday to Friday at our Holborn clinic. We are offering skin-checks, outpatient surgery including biopsies and skin cancer surgery, PDT treatment, along with steroid injections and PRP scalp treatment. We are continuing to offer video …

June 7: Response to Coronavirus (COVID-19) Read More »

We are continuing to provide consultations to our new and existing patients as video consultations using our secure medical video conferencing software. Following your appointment we can organise to post out a prescription, or the medication direct to you, so you can avoid traveling and stay home and keep safe. Our staff are available by …

May 1: Response to Coronavirus (COVID-19) Read More »

We have now redeployed all of our staff and Dermatologists so they are working from home in line with the government directive, and although our Holborn clinic is physically closed, we are providing services to our patients on a remote basis. Dermatology consultations are continuing using video consultations with Skype, FaceTime or where suitable phone …

March 26: Response to Coronavirus (COVID-19) Read More »

March 17, 2020 To all of our patients, At The London Skin and Hair Clinic and London Real Skin, we are deeply committed to prioritizing the health and well-being of our patients, staff, and community. Nothing is more important than your health and safety, and the need to protect those most vulnerable to the coronavirus …

March 17: Response to Coronavirus (COVID-19) Read More »